Emmaus Life Sciences Inc
OTC:EMMA
Balance Sheet
Balance Sheet Decomposition
Emmaus Life Sciences Inc
Emmaus Life Sciences Inc
Balance Sheet
Emmaus Life Sciences Inc
| Sep-2007 | Sep-2008 | Sep-2009 | Sep-2010 | Sep-2011 | Sep-2012 | Sep-2013 | Sep-2014 | Sep-2015 | Sep-2016 | Sep-2017 | Sep-2018 | Dec-2019 | Dec-2020 | Dec-2021 | Dec-2022 | Dec-2023 | Dec-2024 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | |||||||||||||||||||
| Cash & Cash Equivalents |
6
|
2
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
5
|
3
|
2
|
2
|
2
|
2
|
3
|
1
|
|
| Cash |
6
|
2
|
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
5
|
3
|
2
|
2
|
2
|
2
|
3
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
28
|
0
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
6
|
3
|
|
| Accounts Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
2
|
0
|
1
|
0
|
6
|
3
|
|
| Other Receivables |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
8
|
7
|
4
|
2
|
2
|
2
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
1
|
2
|
2
|
1
|
|
| Total Current Assets |
6
|
2
|
1
|
0
|
0
|
0
|
1
|
1
|
1
|
0
|
6
|
4
|
41
|
11
|
9
|
6
|
12
|
7
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
4
|
3
|
2
|
2
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
5
|
4
|
4
|
3
|
2
|
2
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Intangible Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Goodwill |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Long-Term Investments |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
13
|
44
|
44
|
39
|
21
|
15
|
|
| Other Long-Term Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
6
N/A
|
3
-56%
|
1
-56%
|
0
-79%
|
0
+54%
|
0
-65%
|
1
+977%
|
1
-4%
|
1
-57%
|
1
-11%
|
6
+1 096%
|
5
-16%
|
59
+1 055%
|
60
+0%
|
57
-5%
|
48
-15%
|
35
-27%
|
24
-33%
|
|
| Liabilities | |||||||||||||||||||
| Accounts Payable |
0
|
0
|
1
|
1
|
2
|
3
|
2
|
1
|
1
|
0
|
1
|
0
|
7
|
2
|
3
|
4
|
6
|
5
|
|
| Accrued Liabilities |
0
|
1
|
1
|
1
|
1
|
2
|
1
|
0
|
1
|
1
|
1
|
1
|
5
|
7
|
7
|
10
|
13
|
14
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
4
|
7
|
0
|
1
|
0
|
0
|
0
|
0
|
1
|
1
|
9
|
6
|
4
|
4
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
14
|
10
|
13
|
21
|
25
|
24
|
|
| Other Current Liabilities |
0
|
0
|
0
|
2
|
5
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
6
|
4
|
6
|
13
|
15
|
17
|
|
| Total Current Liabilities |
1
|
1
|
2
|
4
|
12
|
13
|
4
|
3
|
2
|
2
|
2
|
1
|
33
|
23
|
37
|
54
|
62
|
64
|
|
| Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
3
|
0
|
0
|
1
|
0
|
3
|
5
|
4
|
2
|
2
|
|
| Minority Interest |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
0
|
0
|
38
|
38
|
36
|
24
|
19
|
14
|
|
| Total Liabilities |
1
N/A
|
2
+139%
|
2
+44%
|
4
+96%
|
12
+166%
|
13
+12%
|
4
-73%
|
3
-13%
|
5
+74%
|
2
-71%
|
2
-2%
|
1
-27%
|
71
+6 140%
|
65
-8%
|
78
+21%
|
82
+5%
|
83
+1%
|
80
-3%
|
|
| Equity | |||||||||||||||||||
| Common Stock |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Retained Earnings |
11
|
17
|
25
|
33
|
42
|
46
|
57
|
59
|
63
|
69
|
76
|
85
|
226
|
225
|
241
|
252
|
256
|
263
|
|
| Additional Paid In Capital |
17
|
18
|
24
|
29
|
31
|
33
|
54
|
57
|
58
|
67
|
80
|
89
|
215
|
219
|
220
|
221
|
225
|
226
|
|
| Other Equity |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
0
|
3
|
17
|
20
|
|
| Total Equity |
5
N/A
|
1
-80%
|
1
N/A
|
4
-278%
|
11
-172%
|
13
-14%
|
2
+83%
|
2
+19%
|
5
-175%
|
1
+78%
|
5
N/A
|
4
-12%
|
11
N/A
|
5
+53%
|
21
-316%
|
34
-59%
|
48
-40%
|
56
-18%
|
|
| Total Liabilities & Equity |
6
N/A
|
3
-56%
|
1
-56%
|
0
-79%
|
0
+54%
|
0
-65%
|
1
+977%
|
1
-4%
|
1
-57%
|
1
-11%
|
6
+1 096%
|
5
-16%
|
59
+1 055%
|
60
+0%
|
57
-5%
|
48
-15%
|
35
-27%
|
24
-33%
|
|
| Shares Outstanding | |||||||||||||||||||
| Common Shares Outstanding |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
1
|
1
|
48
|
49
|
49
|
50
|
62
|
64
|
|